Procter & Gamble Stock Rises on Mixed Earnings, Beauty Segment Offsets US Weakness
Procter & Gamble shares climbed 2.65% to $149.93 despite a slight revenue miss, as strength in its beauty and healthcare divisions compensated for softer US performance. The consumer goods giant posted $22.21 billion in quarterly sales, a 1% increase that fell marginally short of estimates.
Premium beauty demand and strategic pricing drove 5% growth in key segments, while baby care products declined. Gross margins contracted amid product mix challenges and restructuring costs. Management maintained full-year guidance, signaling confidence in its productivity plan that includes cutting up to 7,000 jobs by fiscal 2027.
Investors rewarded the resilience, pushing shares higher in after-hours trading. The company generated $5 billion in operating cash flow, returning $4.8 billion to shareholders through dividends and buybacks—a bullish signal for cash-rich corporations navigating economic headwinds.
